glp-1 and type 2 diabetes GLP-1RAs Reduce External Eating Behavior with GLP-1 receptor agonists | How

CVS says the decision to cover Wegovy and exclude Zepbound is forcing the drug manufacturers to compete with one another and will encourage both Eli Lilly and Novo Nordisk to lower prices for their products in the US

Hogan AE, Gaoatswe G, Lynch L, Corrigan MA, Woods C, O'Connell J, et al

If your Ozempic prescription is tied to a documented medical diagnosis such as Type 2 diabetes, insulin resistance, or prediabetes

Semaglutide: nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: a disproportionality analysis

Nature 494 , 185194 (2013)

Additionally, a pooled analysis of large-scale clinical studies evaluating the cardiorenal advantages of GLP-1RAs in T2DM suggested a trend towards reduced pulmonary adverse events, including asthma, in the GLP-1RAs treatment groups [256]